Torque announces new appointments

Torque, an immuno-oncology company developing first-in-class Deep-Primed T Cell Therapeutics to direct immune power deep...

January 28, 2019 | Monday | News
DZD completes $8.6M series A round

US based start-up, Day Zero Diagnostics, Inc. (DZD) which is an infectious disease diagnostic company using genome seque...

January 28, 2019 | Monday | News
The BHF call for proposals under Big Beat Challenge

The British Heart Foundation (BHF) is calling for researchers and innovators from around the world to apply for one...

January 25, 2019 | Friday | News
Merck enters into an exclusive licensing agreement with Vertex

Merck, a leading science and technology company has announced that it has entered into an exclusive licensing agreement ...

January 25, 2019 | Friday | News
deCODE publishes the first genetic map of the Human Genome

Scientists at deCODE genetics in Iceland, a subsidiary of Amgen has published the first genetic map of the human genome ...

January 25, 2019 | Friday | News
NIH collaborates with AAS and Bill & Melinda Gates

NIH, the African Academy of Sciences, and the Bill & Melinda Gates Foundation are collaborating to establish the Afr...

January 25, 2019 | Friday | News
Eppendorf & Science Prize for Neurobiology 2019: Call for Entries!

Eppendorf and the journal Science are now accepting applications for the 2019 Eppendorf & Science Prize for Neurobio...

January 25, 2019 | Friday | News
Alvotech raises $300mn to further biosimilar development

Alvotech has successfully raised US$300 million through a private bond offering. Net proceeds from the capital raised ...

January 24, 2019 | Thursday | News
Philogen signs drug discovery contract with J & J

Philogen S.p.A., a privately-owned biotechnology company, has announced through its wholly-owned Swiss subsidiary, Philo...

January 24, 2019 | Thursday | News
SSB offers services for characterization of NBEs

Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, announced the launc...

January 24, 2019 | Thursday | News
Vertex announces EC approval for ORKAMBI

Global Biotechnology company, Vertex Pharmaceuticals has announced that the European Commission has granted approval of ...

January 24, 2019 | Thursday | News
Attune Pharma announces $23M Series B Financing

Clinical Stage biotech company, Attune Pharmaceuticals focused on the discovery and development of novel, orally adminis...

January 24, 2019 | Thursday | News
Translate Bio announces FDA clinical hold on IND

Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transfor...

January 23, 2019 | Wednesday | News
Editas Medicine announces CEO Transition

Genome editing company, Editas Medicine has announced that Katrine Bosley has decided to step down from her ro...

January 23, 2019 | Wednesday | News
Novo Holdings invests 4.4M Euro in Minerva to combat AMR

MinervaX, a privately held Danish biotech company has announced that is has been awarded an investment of 3.6 mEUR from ...

January 23, 2019 | Wednesday | News
J&J reports 2018 fourth-quarter results

Johnson & Johnson has announced sales of $20.4 billion for the fourth quarter of 2018, an increase of 1.0% as compar...

January 23, 2019 | Wednesday | News
Wren Therapeutics completes £18M Series A Financing

UK based biopharma company, Wren Therapeutics focused on drug discovery and development for protein misfolding diseases ...

January 23, 2019 | Wednesday | News
Gamida Cell collaborates with Be The Match BioTherapies

Clinical stage Biopharmaceutical Company, Gamida Cell Ltd. and Be The Match BioTherapies, a subsidiary of the National M...

January 23, 2019 | Wednesday | News